Correction to: J Ovarian Res (2019) 12:56
https://doi.org/10.1186/s13048-019-0526-0
Following publication of the original article [1], the authors opted to correct the incorrect e-mail address of the corresponding author from 82-55-360-1850chungsu1982@gmail.com to chungsu1982@gmail.com, grant in the Acknowledgements section and Author details. Below are the updated version of the Acknowledgements and Author details.
Reference
Kim KH, Choi KU, Kim A, Lee SJ, Lee JH, Suh DS, Kwon BS, Hwang C. PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma. J Ovarian Res. 2019;12:56 https://doi.org/10.1186/s13048-019-0526-0.
Acknowledgements
This study was supported by Biomedical Research Institute Grant (2017-10), Pusan National University Hospital. The biospecimens for this study were provided by the Biobank of Pusan National University Hospital, a member of the National Biobank of Korea, which is supported by the Ministry of Health, Welfare and Family Affair.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Kim, K.H., Choi, K.U., Kim, A. et al. Correction to: PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma. J Ovarian Res 12, 68 (2019). https://doi.org/10.1186/s13048-019-0540-2
Published:
DOI: https://doi.org/10.1186/s13048-019-0540-2